Skip to main content
. 1998 Dec;114(3):408–413. doi: 10.1046/j.1365-2249.1998.00752.x

Fig. 4.

Fig. 4

IgG subclass distribution of sodium antimony gluconate (SAG)-responsive kala-azar patients before (□) and after (▪) a single course of SAG treatment compared with healthy controls (??).Sera were diluted 1:50 and assayed by ELISA.